For example, a bispecific CAR molecule directed against both IL13Rα2 and HER2 (TanCAR) has been shown to promote tumor regression and increase survival in mice xenografted with a HER2+ IL13Rα2+ human glioblastoma cell line compared to CAR T cells against either target alone (133). Here, IL13RA2 is linked to neoplasm.